Italy Respiratory Devices Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 6.80 % |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Italy Respiratory Devices Market Analysis
The Italian respiratory devices market is poised to register a CAGR of 6.8% over the forecast period. The COVID-19 pandemic sparked a rush in the pharmaceutical sector to produce therapeutic and preventive medications. The pandemic favorably impacted the Italian respiratory devices business. According to a study published in the Journal of Respiratory Research in January 2021, COVID- 19 patients had acute respiratory distress syndrome (ARDS), required breathing support, and some had to be hospitalized in the critical care unit (ICU). COVID-19 patients also experienced severe hypoxia with respiratory failure, along with other signs, such as tachypnoea, increased use of accessory muscles, tachycardia, pale and cold periphery, sweating, confusion, agitation, or decreased level of consciousness, and cyanosis. Thus, the demand for respiratory devices significantly increased during the pandemic to provide respiratory support for COVID-19 patients. This positively impacted the growth of the market. Moreover, the market is expected to grow over the forecast period as all COVID-related restrictions have been lifted, and market growth is rebounding by rising respiratory diseases and product launches.
The market for respiratory devices has been growing in Italy due to the increasing prevalence of respiratory disorders, such as chronic obstructive pulmonary disease (COPD), TB, Asthma, and sleep apnoea. According to a study published in the National Library of Medicine in March 2022, the CB phenotype was prevalent (48.3%), followed by the E and the A phenotypes (38.8% and 12.8%, respectively). When dyspnoea was the prevailing symptom, the probability of belonging to the COPD-E phenotype was 3.40 times higher. These phenotypes are responsible for the worsening of the COPD . Thus, the increase in the occurrence of the COPD among the Italian population is expected to drive the demand for the respiratory devices over the forecast period.
The country's increasing asthma burden necessitates the use of respiratory devices. According to a study published in the Journal of Asthma in August 2021, the prevalence of asthma in Italy was believed to be around 4%, affecting roughly 2,000,000 persons. Up to 80-90% of patients experience mild-to-moderate asthma each year. Thus, the growing prevalence of respiratory diseases in the country, such as COPD and asthma, are likely to support the growth of the market.
Thus, the aforementioned factors are expected to drive the growth of the market over the forecast period. However, the high cost of devices and instruments might restrain market growth.
Italy Respiratory Devices Market Trends
This section covers the major market trends shaping the Italy Respiratory Devices Market according to our research experts:
Ventilators as Therapeutic Devices Expected to Register Significant Growth
A ventilator is a piece of medical technology that offers mechanical ventilation by transferring breathable air in and out of the lungs to deliver breaths to a patient who is physically unable or insufficiently breathing. The segment is driven by the increasing prevalence of respiratory diseases and strategic activities by market players. According to updates in 2022 by World Data Atlas, in 2020, the incidence of tuberculosis in Italy was 6.6 cases per 100,000 people. Thus, with the growing incidence of respiratory diseases, the demand for ventilators is expected to rise in the country, thereby boosting segment growth.
Strategic activities by market players, such as product launches, mergers, and acquisitions, collaboration, and partnerships, are likely to support the growth of the market. For instance, in March 2020, the Swedish medical equipment group Getinge GETIb.ST delivered 500 ventilators to Italy, which was hit the hardest by the pandemic, and tendered 5,000 ventilators and other desperately needed medical equipment. In March 2020, Italian 3D printing start-up ISINNOVA saved the lives of ten Covid-19 patients after developing a replacement ventilator valve, when supplies at Chiari hospital in Brescia ran dry. In April 2020, Mechanical Ventilator Milano, or MVM, collaboration based in Italy created a safe and reliable ventilator for COVID-19 patients, built from widely available parts. Such technological advancement and strategic initiatives by market players are likely to support the expansion of the segment over the forecast period.
Thus, the above-mentioned factors are expected to boost the growth of the ventilators segment in the country over the forecast period.
Inhalers is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
An inhaler is a device that delivers medication straight to the lungs. A device for administering medications as a spray that is inhaled (breathed in) through the nose or the mouth. Major factors attributing to the growth of the digital dose inhaler market include the rising prevalence of chronic respiratory diseases and the growing demand for technology-enabled features of inhaler devices.
The burden of respiratory diseases, such as asthma, COPD, tuberculosis, lung cancers, and others, is growing. According to a study published in the International Journal of Environmental Research and Public Health in March 2022, the incidence of idiopathic pulmonary fibrosis in Italy was 9.8 instances per 100,000 person-years. A significant annual increase of 6% was recorded. Males had a much greater incidence rate than females and older populations with poor health outcomes. Thus, the rising prevalence of respiratory disorders drives the demand for effective treatment options, enhancing the growth of the inhaler segment.
Additionally, strategic activities by market players are expected to support market expansion over the forecast period. For instance, in March 2022, Kither Biotech, a biopharmaceutical business based in Turin, Italy, that is exploring innovative medicines for rare respiratory disorders, raised EUR 18.5 million (USD 19.53 million) in Series B funding. This funding is expected to be used for bringing technologically advanced respiratory products into the market, thereby boosting the market growth.
Italy Respiratory Devices Industry Overview
The Italian respiratory devices market is moderately competitive and fragmented, with several major players. Some strategies implemented include agreements, collaborative models, business expansion, and product development. Italy is a developed country with a well-structured healthcare system. Some market players are Dragerwerk AG, Fisher & Paykel Healthcare Ltd, Fosun Pharmaceutical (Breas Medical AB), GE Healthcare, GlaxoSmithKline PLC, Invacare Corporation, and Koninklijke Philips NV, among others.
Italy Respiratory Devices Market Leaders
-
GE Healthcare
-
Fisher & Paykel Healthcare Ltd
-
Medtronic PLC
-
ICU Medical (Smiths Medical Inc)
-
Invacare Corporation
*Disclaimer: Major Players sorted in no particular order
Italy Respiratory Devices Market News
- In July 2022, the Bastide Group announced the purchase of a majority stake in Oxystore, an Italian company near Milan. Oxystore specializes in consumer home diagnosis and online sales of oxygen therapy and sleep apnea devices. It also provides support and follow-up services to patients receiving home treatment.
- In February 2022, ProSomnus Sleep Technologies, one of the leaders in patient-preferred medical devices for the treatment of obstructive sleep apnea (OSA), displayed four poster abstracts of its oral appliance therapy (OAT) devices at the World Sleep Congress 2022, which was held in March 2022, in Rome, Italy.
Italy Respiratory Devices Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Increasing Prevalence of Respiratory Disorders
- 4.2.2 Technological Advancements and Increasing Applications in Homecare Settings
-
4.3 Market Restraints
- 4.3.1 High Cost of Devices
-
4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD Million)
-
5.1 By Type
- 5.1.1 By Diagnostic and Monitoring Devices
- 5.1.1.1 Spirometers
- 5.1.1.2 Sleep Test Devices
- 5.1.1.3 Other Diagnostic and Monitoring Devices
- 5.1.2 By Therapeutic Devices
- 5.1.2.1 Positive Airway Pressure (PAP) Devices
- 5.1.2.2 Humidifiers
- 5.1.2.3 Nebulizers
- 5.1.2.4 Ventilators
- 5.1.2.5 Inhalers
- 5.1.2.6 Other Therapeutic Devices
- 5.1.3 By Disposables
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Dragerwerk AG
- 6.1.2 Fisher & Paykel Healthcare Ltd
- 6.1.3 Fosun Pharmaceutical (Breas Medical AB)
- 6.1.4 GE Healthcare
- 6.1.5 GlaxoSmithKline PLC
- 6.1.6 Invacare Corporation
- 6.1.7 Koninklijke Philips NV
- 6.1.8 Medtronic PLC
- 6.1.9 ICU Medical (Smiths Medical Inc.)
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityItaly Respiratory Devices Industry Segmentation
As per the scope of the report, respiratory devices include respiratory diagnostic devices, therapeutic devices, and breathing devices for administering long-term artificial respiration. It may also include a breathing apparatus used for resuscitation by forcing oxygen into the lungs of a person who has undergone asphyxia. The Italian respiratory devices market is segmented by Type (diagnostic and monitoring devices, therapeutic devices, and disposables). The report offers all values in USD million for the above segments.
| By Type | By Diagnostic and Monitoring Devices | Spirometers |
| Sleep Test Devices | ||
| Other Diagnostic and Monitoring Devices | ||
| By Type | By Therapeutic Devices | Positive Airway Pressure (PAP) Devices |
| Humidifiers | ||
| Nebulizers | ||
| Ventilators | ||
| Inhalers | ||
| Other Therapeutic Devices | ||
| By Type | By Disposables |
Italy Respiratory Devices Market Research FAQs
What is the current Italy Respiratory Devices Market size?
The Italy Respiratory Devices Market is projected to register a CAGR of 6.80% during the forecast period (2024-2029)
Who are the key players in Italy Respiratory Devices Market?
GE Healthcare, Fisher & Paykel Healthcare Ltd, Medtronic PLC, ICU Medical (Smiths Medical Inc) and Invacare Corporation are the major companies operating in the Italy Respiratory Devices Market.
What years does this Italy Respiratory Devices Market cover?
The report covers the Italy Respiratory Devices Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Italy Respiratory Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Molded Pulp Packaging Industry Report
Statistics for the 2024 Molded Pulp Packaging market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Molded Pulp Packaging analysis includes a market forecast outlook 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
